The biotechnology sector is a rapidly-evolving space, and biotech traders must always stay on top of the latest developments. Here is a roundup of several recent biotech developments that are worth keeping an eye on.
Arena Collaborates With Roivant On Nelotanserin
Arena Pharaceuticals Inc (NASDAQ: ARNA) recently announced that its subsidiary Arena Pharmaceuticals GmbH has entered into a Development, Marketing and Supply Agreement with Roivant Sciences Ltd for nelotanserin. Nelotanserin is Arena’s internally-discovered inverse agonist of the 5-HT2A receptor. Under the terms of the agreement, Roivant will now be the exclusive worldwide developer and marketer of nelotanserin.
Hey, check out all the research scientist jobs. Post your resume today!
